계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Rain Therapeutics
company
About
Rain Therapeutics is a operator of a clinical stage biotechnology company.
- 1 - 10
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $18.36M
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Jan 1, 2017
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Rain Therapeutics develops targeted therapies for patients with cancer. We begin by identifing cancers with a single, and clear, oncogenic driver and evaluating sub-populations of cancer populations with an unmet need, where standards of care are ineffective. Our global scientific and thought-leader network drives our asset and technology identification to match these cancers with small molecule therapeutics targeted at treating specific cancer mutations.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$18.36M
Rain Therapeutics has raised a total of
$18.36M
in funding over 2 rounds. Their latest funding was raised on
May 21, 2018 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 21, 2018 | Series A | $18.36M | 1 | — | — | Detail |
Investments
Number of Investments
Number of Lead Investments
2
0
Rain Therapeutics has made 2 investments. Their most recent investment was on
Nov 11, 2015, when MONI raised $1.75M.
Investors
Number of Lead Investors
Number of Investors
—
1
Rain Therapeutics is funded by 1 investors.
University of Auckland Inventors Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
